Psychiatric effects of ephedra use: An analysis of food and drug administration reports of adverse events

American Journal of Psychiatry

Volumn 162, Issue 1, 2005, Pages 189-191

  Maglione, Margaret ^a,b   Miotto, Karen ^a   Iguchi, Martin ^a   Jungvig, Lara ^a   Morton, Sally C ^a   Shekelle, Paul G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRA EXTRACT; HERBACEOUS AGENT; ILLICIT DRUG;

ADULT; AGITATION; CRIMINAL BEHAVIOR; DEPRESSION; DIET SUPPLEMENTATION; DIZZINESS; DRUG SCREENING; FOOD AND DRUG ADMINISTRATION; HALLUCINATION; HEART PALPITATION; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MANIA; MENTAL DISEASE; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; RAGE; REVIEW; SIDE EFFECT; SLEEP DISORDER; SUICIDAL BEHAVIOR;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; DIETARY SUPPLEMENTS; EPHEDRA; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PLANT PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 11844290644     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.1.189     Document Type: Review

References (10)

1. Hardman JG, Limbird LE, Gilman A: Goodman and Gilman's The Pharmacologic Basis of Disease, 10th ed. New York, McGraw-Hill, 2001
2. Burnham TH, Novak KK, Bell WL, Schweain SL: Ephedrine, in Drug Facts and Comparisons. St Louis, Facts and Comparisons, 2002
3. Robinson TE, Backer JB: Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986; 396:157-198
4. Martin WR, Sloan JW, Sapira JD, Jasinski DR: Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971; 12:245-258
5. Haller CA, Benowitz NL: Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000; 343:1833-1838
6. Department of Health and Human Services: HHS announces plans to study ephedra. HHS News, June 14, 2002
7. Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagne J: Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003; 289:1537-1545
8. Tinsley JA, Watkins DD: Over-the-counter stimulants: abuse and addiction. Mayo Clin Proc 1998; 73:977-982
9. Boutros NN, Bowers MB: Chronic substance-induced psychotic disorders: state of the literature. J Neuropsychiatry 1996; 8:262-269
10. US Department of Health and Human Services and Office of Inspector General: Adverse Event Reporting for Dietary Supplements: An Inadequate Safety Valve: Publication OEI-01-00-00180. Washington, DC, US DHHS, 2001